|
Volume 272, Number 26,
Issue of June 27, 1997
pp. 16288-16294
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Repression of -Aminobutyric Acid Type A Receptor 1
Polypeptide Biosynthesis Requires Chronic Agonist Exposure
(Received for publication, September 4, 1996, and in revised form, April 8, 1997)
Jorge D.
Miranda
and
Eugene M.
Barnes
Jr. ¶
From the Neuroscience Division and ¶ Department
of Biochemistry, Baylor College of Medicine, Houston, Texas 77030
Although it is well established that
the number of -aminobutyric acid type A (GABAA)
receptors declines in cortical neurons exposed to GABAA
receptor agonists, the mechanisms responsible for this
use-dependent down-regulation remain unclear. Two
hypotheses have been proposed: (i) agonist-evoked sequestration and
degradation of surface GABAA receptors and (ii) repression
of receptor subunit biosynthesis. We have addressed this problem using
[35S]Met/Cys pulse-chase labeling of chick cortical
neurons in culture and immunoprecipitation and immunoblotting with an
antibody (RP4) directed against a GABAA receptor
1-(331-381) fusion protein. Exposure of the cells to GABA or
isoguvacine for 2 h to 4 days had no effect on the initial rate of
35S incorporation into the GABAA receptor
51-kDa 1 polypeptide, but this rate declined by 33% after a 7-day
treatment. This is consistent with a previous report (Baumgartner, B. J., Harvey, R. J., Darlison, M. G., and Barnes, E. M. (1994) Mol.
Brain Res. 26, 9-17) that a 7-day GABA treatment of this
preparation produced a 45% reduction in the 1 subunit mRNA
level, while a 4-day exposure had no detectable effect. On the other
hand, after a 4-day exposure to these agonists, a 30% reduction in the
level of the 1 polypeptide was observed on immunoblots, similar to
that found previously for down-regulation of GABAA receptor
ligand-binding sites. Thus, the de novo synthesis of
GABAA receptor 1 subunits is subject to a delayed
use-dependent repression that was observed after, rather
than before, the decline in neuronal levels of the polypeptide.
Pulse-chase experiments showed a monophasic degradation of the
GABAA receptor 35S- 1 subunit with a
t1/2 = 7.7 h, a process that was unaffected by
the addition of GABA to neurons during the chase period. These nascent
35S-labeled polypeptides are presumably diluted into the
neuronal pool of unlabeled unassembled 1 subunits, which was found
to exceed by a 4:1 molar ratio the amount assembled into
[3H]flunitrazepam binding sites. Thus, the data reveal an
alternative scheme for degradation of GABAA receptor
polypeptides: a pathway that may participate in the agonist-independent
degradation of unassembled receptor subunits. This differs from another
pathway for the agonist-dependent degradation of mature
GABAA receptors derived from the neuronal surface (Calkin,
P. A., and Barnes, E. M., Jr. (1994) J. Biol. Chem.
269, 1548-1553).

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Eisensamer, M. Uhr, S. Meyr, G. Gimpl, T. Deiml, G. Rammes, J. J. Lambert, W. Zieglgansberger, F. Holsboer, and R. Rupprecht
Antidepressants and Antipsychotic Drugs Colocalize with 5-HT3 Receptors in Raft-Like Domains
J. Neurosci.,
November 2, 2005;
25(44):
10198 - 10206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Gravielle, R. Faris, S. J. Russek, and D. H. Farb
GABA Induces Activity Dependent Delayed-onset Uncoupling of GABA/Benzodiazepine Site Interactions in Neocortical Neurons
J. Biol. Chem.,
June 3, 2005;
280(22):
20954 - 20960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. J. Tehrani and E. M. Barnes Jr.
Sequestration of gamma -Aminobutyric AcidA Receptors on Clathrin-Coated Vesicles During Chronic Benzodiazepine Administration In Vivo
J. Pharmacol. Exp. Ther.,
October 1, 1997;
283(1):
384 - 390.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|